vivoPharm offers a number of well-characterised human tumour subcutaneous xenografts. We employ optimised and standardised methods to assess the anti-tumour efficacy of single compounds (monotherapy) or combination therapy with standard therapeutics or development compounds. A large collection of reference data is available. The growth kinetics of each tumour model that we offer have been well characterized.